Go Deep
DataMEDS AI, Inc.
DataMEDS AI, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | -16,736 | -0.1 | -0.66 | -1.99 | 269.94 |
| Oct 2026 | -16,695 | -0.1 | -0.61 | -1.99 | 249.10 |
| Oct 2026 | -19,303 | -0.1 | -0.62 | -1.99 | 253.16 |
| Oct 2026 | -19,318 | -0.1 | -0.64 | -1.99 | 260.75 |
| Oct 2026 | -19,312 | -0.1 | -0.63 | -1.99 | 257.26 |
| Oct 2026 | -19,235 | -0.0 | -0.53 | -1.99 | 217.10 |
DataMEDS AI, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 1,779,860.0 | 1,559,563.0 | 1,670,648.0 | 3,012,904.0 |
| Net Profit | -18,363,225.0 | -7,742,597.0 | -27,852,959.0 | -34,318,204.0 |
| EPS | -7.1 | -3.5 | — | -23.0 |
DataMEDS AI, Inc. Revenue & Profit: Last 4 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | 23,337,860.0 | 18,128,831.0 | 0.0 | 32,777,728.0 |
| Net Profit | -101,274,530.0 | -6,856,226.0 | -2,895,684.0 | -2,743,800.0 |
| EPS | -71.5 | -7.5 | -3.0 | -2.9 |
DataMEDS AI, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Total Assets | 30,459,449.0 | 57,332,650.0 | 338,364.0 | 0.0 |
| Total Liabilities | 42,907,250.0 | 50,598,204.0 | 3,238,798.0 | 5,250.0 |
| Total Equity | -12,447,801.0 | 6,734,446.0 | -2,900,434.0 | -5,250.0 |
Owes vs Owns
DataMEDS AI, Inc. owed $1.60 for every $1 it owned in Jun 2026, down from $9.57 in Dec 2023.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|---|---|
| Owes vs Owns | 1.60× | 1.41× | 0.88× | 9.57× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
DataMEDS AI, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Receivables 3.7%Inventory 5.4%Fixed assets (tangible) 3.9%Intangible assets 86.5%
How it's funded — Dec 2025
Short-term debt 25.8%Long-term debt 29.4%Payables 27.2%Other liabilities 17.6%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|---|
| Assets | |||
| Cash & short-term investments | 0.0 | 1.0 | 0.0 |
| Receivables | 1.1 | 3.7 | 0.3 |
| Inventory | 1.6 | 9.5 | 0.0 |
| Fixed assets (tangible) | 1.2 | 1.9 | 0.0 |
| Intangible assets | 26.4 | 38.6 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 |
| Other assets | 0.1 | 2.5 | 0.0 |
| Liabilities & equity | |||
| Short-term debt | 11.1 | 12.0 | 0.3 |
| Long-term debt | 12.6 | 11.5 | 0.3 |
| Payables | 11.7 | 6.3 | 1.0 |
| Other liabilities | 7.5 | 20.8 | 1.5 |
| Shareholders' equity | -12.4 | 6.7 | -2.9 |
| Net tangible assets | -38.8 | -31.8 | -2.9 |
DataMEDS AI, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Operating Activities | -10,855,029.0 | -1,224,993.0 | -349,136.0 | 0.0 |
| Investing Activities | -881,526.0 | 469,072.0 | 0.0 | — |
| Financing Activities | 10,750,790.0 | 1,782,893.0 | 350,500.0 | 0.0 |